DNA 및 RNA 합성 조사 리뷰(2025년)

The global market for DNA read, write, and edit was valued at $25.9 billion in 2025 and is estimated to reach $67.7 billion by 2030, at a compound annual growth rate (CAGR) of 21.2% from 2025 through 2030.

The global market for DNA forensics is projected to grow from an estimated $3.3 billion in 2025 to $4.7 billion by the end of 2030, at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2030.

The global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029.

Report Scope

DNA and RNA synthesis artificially manufacture deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). Developing synthetic techniques to construct DNA and RNA has improved the ability to understand and engineer biology. Different types of synthesized DNA, such as oligonucleotides, genes, and DNA and RNA fragments, are available and can be tailored to customer needs. Synthetic DNA and RNA are used to develop new drugs and vaccines, gene therapies for genetic disorders, and the development of molecular diagnostic tools, including polymerase chain reaction (PCR) assays and nucleic-acid-based sensors, to detect pathogens and diseases.

DNA and RNA synthesis technology is vital in scientific fields such as synthetic biology, molecular genetics, and bioengineering, creating custom DNA and RNA sequences for various research, diagnostic, and therapeutic applications. The rapid expansion of genomics research, advances in therapeutic DNA and RNA applications, and the growing need for personalized medicine are driving exceptional growth in the DNA and RNA synthesis market. The innovations in Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), gene therapy, and synthetic biology show that the demand for DNA and RNA synthesis has risen sharply, positioning it as a pivotal tool in developing targeted treatments and innovative genetic research solutions.

Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. This 2025 Research Review of DNA and RNA synthesis technology provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions. This Research Review includes highlights and excerpts from the following reports published by BCC Research in 2025:

• BIO193B Global DNA Read, Write, and Edit Market
• BIO152C The Chinese Market for DNA Sequencing
• BIO266A Global DNA Forensics Market
• PHM044D Epigenetics: Technologies and Global Markets
• BIO212C mRNA: Therapeutics and Global Markets
• BIO146D Genome Editing: Technologies and Global Markets
• BIO159B Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies, and Gene Editing
• BIO080F Cell-Based Assays: Technologies and Global Markets

After you survey the excerpts in this Research Review, we encourage you to follow up on these topics by checking out the full market research reports associated with each topic. BCC Research looks forward to serving your market intelligence needs in the future.

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Global DNA Read, Write, and Edit Market (BIO193B)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion
• Current Market Overview
• Sequencing Technologies
• Sanger Sequencing
• Third-Generation Sequencing
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies of Advances in Sequencing Technologies
• Advances in Sequencing Technologies
• Market Analysis by Technology
• Key Takeaways
• DNA Read (Sequencing)
• DNA Write (Synthesis)
• DNA Edit (Genome Editing)
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability to ESG Perspective
• ESG Practices in the DNA Read, Write, and Edit Industry
• Environmental Performance
• ESG Risk Ratings
• Conclusion

Chapter 3 The Chinese Market for DNA Sequencing (BIO152C)

• Market Outlook
• Scope of Report
• Market Summary
• Technological Advances
• Market Dynamics and Growth Factors
• Segmental Analysis
• Conclusion
• Market Overview
• Market Dynamics
• Market Driver
• Market Restraints
• Market Opportunities
• Emerging technologies and Developments
• Long-Read Sequencing Technologies
• Single-Molecule Real-Time (SMRT) Sequencing
• Artificial Intelligence (AI) and Machine Learning in DNA Sequencing
• Market Analysis by Product and Services
• Instruments and Consumables
• Services
• Chinese DNA Sequencing Market Analysis, by Technology
• Next-Generation Sequencing (NGS)
• Third-Generation Sequencing
• Sanger Sequencing
• Pyrosequencing
• Chinese DNA Sequencing Market Analysis, by Province

Chapter 4 Global DNA Forensics Market (BIO266A)

• Market Outlook
• Scope of Report
• Market Summary
• Technological Advances
• Market Dynamics and Growth Drivers
• Segmental Analysis
• Regional Analysis
• Conclusion
• Market Overview
• Market Dynamics
• Market Driver
• Market Restraint
• Market Opportunities
• Emerging Technologies Newest Technologies/Trends
• NGS
• NGI System
• Market Breakdown
• Key Takeaways
• Kits and Consumables
• Equipment
• Software
• Market Analysis by Source
• Key Takeaways
• Blood
• Bones
• Hair
• Others
• Market Analysis by Technique
• Key Takeaways
• PCR Amplification
• Short Tandem Repeat
• Capillary Electrophoresis
• NGS
• Others
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Middle East and Africa
• Sustainability in the Global DNA Forensics Industry
• ESG Risks and Ratings: Understanding the Data
• Concluding Remarks on ESG

Chapter 5 Epigenetics: Technologies and Global Markets (PHM044D)

• Market Outlook
• Scope of Report
• Market Summary of Epigenetics: Technologies
• Market Overview of RNA Sequencing
• Epigenetics Overview
• DNA Methylation
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Trends
• Emerging Technologies and Developments
• Epigenome Editing
• Market Breakdown
• Market Overview
• Market Size and Forecast
• DNA Methylation
• Histone Modification
• RNA Modification
• Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Introduction to ESG
• Key ESG Issues in Epigenetics Pharmaceuticals andDiagnostics Market
• Sustainability Practices in Pharmaceuticals Manufacturing
• Sustainable Packaging
• Key ESG Issues in Epigenetics Research Tools Market
• ESG Risk Ratings Score - Understanding the Data
• Concluding Remarks

Chapter 6 mRNA: Therapeutics and Global Markets (BIO212C)

• Market Outlook
• Scope of Report
• Market Summary
• Market Growth Factors
• Emerging Technologies
• COVID mRNA Vaccines
• Regional Analysis
• Conclusion
• Market Overview
• Evolution of RNA Therapeutics
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• Nanoparticles
• Modified mRNA
• Market Analysis
• Takeaways
• COVID mRNA Vaccines
• Non-COVID mRNA Vaccines and Therapeutics
• Market Breakdown Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the mRNA Therapeutics Industry
• ESG Risk Ratings
• ESG Performance Analysis
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC Research

Chapter 7 Genome Editing: Technologies and Global Markets (BIO146D)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Market Dynamics
• Market Driver
• Market Restrains
• Market Opportunities
• Market Challenges
• Emerging Technologies
• In Vivo Delivery of CRISPR
• Market Breakdown
• CRISPR-Cas
• TALEN
• Market by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Introduction to ESG
• Sustainability in Genome Editing: An ESG Perspective
• ESG Issues
• ESG Performance Analysis
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC

Chapter 8 Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies, and Gene Editing (BIO159B)

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies
• In Vivo Delivery of CRISPR
• Market Breakdown
• Key Takeaways
• RNA Therapy
• Gene-Modified Cell Therapy
• Gene Therapy
• Gene Editing
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Introduction to ESG
• ESG Risk Ratings
• Conclusion

Chapter 9 Cell-Based Assays: Technologies and Global Markets (BIO080F)

• Market Outlook
• Scope of Report
• Market Summary
• Market Overview
• Market Dynamics
• Market Drivers
• Market Restraints
• Market Opportunities
• Emerging Technologies and Developments
• AI and Machine Learning (ML) in Data Analysis
• Market Breakdown
• Cell-based Assays: Global Markets
• Consumables
• Instruments
• Software
• Services
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Sustainability in the Cell-based Assay Market
• Animal Testing
• Miniaturization and Automation
• Green Chemistry and Eco-friendly Materials
• 3D Cell Cultures and Tissue Models
• Waste Reduction and Optimization of Resources
• Improving Drug Discovery Efficiency
• ESG Risks and Ratings: Understanding the Data
• BCC Research Viewpoint

Chapter 10 Appendix

• Methodology
• Analyst's Credentials